1. Home
  2. JLL vs WST Comparison

JLL vs WST Comparison

Compare JLL & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jones Lang LaSalle Incorporated

JLL

Jones Lang LaSalle Incorporated

HOLD

Current Price

$338.47

Market Cap

15.7B

Sector

Finance

ML Signal

HOLD

Logo West Pharmaceutical Services Inc.

WST

West Pharmaceutical Services Inc.

HOLD

Current Price

$294.91

Market Cap

18.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JLL
WST
Founded
1997
1923
Country
United States
United States
Employees
48000
N/A
Industry
Real Estate
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.7B
18.5B
IPO Year
1997
2004

Fundamental Metrics

Financial Performance
Metric
JLL
WST
Price
$338.47
$294.91
Analyst Decision
Buy
Buy
Analyst Count
7
7
Target Price
$365.33
$325.86
AVG Volume (30 Days)
359.5K
865.5K
Earning Date
04-30-2026
04-23-2026
Dividend Yield
N/A
0.30%
EPS Growth
45.13
1.49
EPS
16.40
1.92
Revenue
$26,115,600,000.00
$2,886,900,000.00
Revenue This Year
$7.71
$6.76
Revenue Next Year
$6.99
$6.22
P/E Ratio
$20.82
$151.68
Revenue Growth
11.45
1.95
52 Week Low
$211.86
$203.74
52 Week High
$363.06
$322.34

Technical Indicators

Market Signals
Indicator
JLL
WST
Relative Strength Index (RSI) 58.62 66.05
Support Level $334.29 $257.29
Resistance Level $359.64 $322.34
Average True Range (ATR) 9.54 8.47
MACD 0.27 2.47
Stochastic Oscillator 53.90 62.06

Price Performance

Historical Comparison
JLL
WST

About JLL Jones Lang LaSalle Incorporated

Jones Lang LaSalle provides a wide range of real estate-related services to owners, occupiers, and investors worldwide, including leasing, property and project management, and capital markets advisory. JLL's investment management arm, LaSalle Investment Management, manages over $86 billion for clients across diverse public and private real estate strategies.

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

Share on Social Networks: